Fractionated high-dose-rate brachytherapy as monotherapy in prostate cancer: Does implant displacement and its correction influence acute and late toxicity?

Shafak Aluwini; Wendy Busser; EA Baartman; Anand Bhawanie; Wendimagegn Ghidey Alemayehu; Joost Boormans; Inger-karine Kolkman - Deurloo

doi:10.1016/j.brachy.2016.05.008

Fractionated high-dose-rate brachytherapy as monotherapy in prostate cancer: Does implant displacement and its correction influence acute and late toxicity?

Shafak Aluwini, Wendy Busser, EA Baartman, Anand Bhawanie, Wendimagegn Ghidey Alemayehu, Joost Boormans, Inger-karine Kolkman - Deurloo

External organisation

Research output: Contribution to journal › Article › Academic

7 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	707-713
Number of pages	7
Journal	Brachytherapy
Volume	15
Issue number	6
DOIs	https://doi.org/10.1016/j.brachy.2016.05.008
Publication status	Published - 2016

Research programs

EMC MM-03-32-04
EMC MM-03-49-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.brachy.2016.05.008

Cite this

@article{0efc63d184c44df794241a08c62dc5de,

title = "Fractionated high-dose-rate brachytherapy as monotherapy in prostate cancer: Does implant displacement and its correction influence acute and late toxicity?",

author = "Shafak Aluwini and Wendy Busser and EA Baartman and Anand Bhawanie and \{Ghidey Alemayehu\}, Wendimagegn and Joost Boormans and \{Kolkman - Deurloo\}, Inger-karine",

year = "2016",

doi = "10.1016/j.brachy.2016.05.008",

language = "Undefined/Unknown",

volume = "15",

pages = "707--713",

journal = "Brachytherapy",

issn = "1538-4721",